Evidence map›Paper›PMID 40365461›Full record

ArticleNature. Mental health2025

Genetic susceptibility to schizophrenia through neuroinflammatory pathways associated with retinal thinness.

Finn Rabe, Lukasz Smigielski, Foivos Georgiadis, Nils Kallen, Wolfgang Omlor, Victoria Edkins, Matthias Kirschner, Flurin Cathomas, Edna Grünblatt, Steven Silverstein and 6 more

Abstract read
In one paragraph

Article in Nature. Mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Finn Rabe *Department of Adult Psychiatry and Psychotherapy, University of Zurich, Zurich, Switzerland.ORCID 0009-0007-2897-5204
Lukasz Smigielski *Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.
Foivos GeorgiadisDepartment of Adult Psychiatry and Psychotherapy, University of Zurich, Zurich, Switzerland.
Nils KallenDepartment of Adult Psychiatry and Psychotherapy, University of Zurich, Zurich, Switzerland.
Wolfgang OmlorDepartment of Adult Psychiatry and Psychotherapy, University of Zurich, Zurich, Switzerland.
Victoria EdkinsDepartment of Adult Psychiatry and Psychotherapy, University of Zurich, Zurich, Switzerland.
Matthias KirschnerDepartment of Adult Psychiatry and Psychotherapy, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-9486-1439
Flurin CathomasDepartment of Adult Psychiatry and Psychotherapy, University of Zurich, Zurich, Switzerland.
Edna GrünblattDepartment of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.ORCID 0000-0001-8505-7265
Steven SilversteinDepartment of Psychiatry, University of Rochester Medical Center, Rochester, NY USA.
Brittany BloseDepartment of Psychiatry, University of Rochester Medical Center, Rochester, NY USA.
Daniel BarthelmesDepartment of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Karen SchaalDepartment of Ophthalmology, Inselspital University Hospital Bern, Bern, Switzerland.
Jose RubioInstitute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY USA.
Todd LenczInstitute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY USA.
Philipp HomanDepartment of Adult Psychiatry and Psychotherapy, University of Zurich, Zurich, Switzerland.ORCID 0000-0001-9034-148X

Funding

Cognitive Genomics as a Window on Neurodevelopment and PsychopathologyR01MH117646 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI TODD LENCZ · 2018 to 2026
$4.7M
Striatal Function in Psychosis RelapseK23MH127300 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI RUBIO, JOSE M · 2021 to 2024
$689k
NIMH NIH HHS K23 MH127300NIMH NIH HHS R01 MH117646
6 · The paper itself

Abstract

Schizophrenia is associated with structural and functional changes in the central nervous system, including the most distal part of it, the retina. However, the question of whether retinal atrophy is present before individuals develop schizophrenia or is a secondary consequence of the disorder remains unanswered. Here we address this question by examining the association between polygenic risk scores for schizophrenia and retinal morphologies in individuals without a schizophrenia diagnosis. We used population data for 34,939 white British and Irish individuals from the UK Biobank. Our robust regression results show that higher polygenic risk scores for schizophrenia were associated with thinner overall maculae, while controlling for confounding factors (

Indexed as

Diagnostic markersGenetics researchSchizophrenia

Identifiers

PMID40365461
PMCPMC12066354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.